Unknown Diabetes, Hormones & Metabolism NIHR-supported project Cancer
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the treatment of Hyperpagia in Prader-Willi Syndrome
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Mars Skae (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients with Prader-Willi Syndrome
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Prostate Cancer
A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to asses the efficacy, safety, and tolerability of subcuntaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease
NAT-19/GPX - Double-blind, randomised, placebo-controlled, dose-finding phase IIb trial to evaluate the efficacy, safety, and tolerability of a 12-week treatment with Naronapride in adult participants with at least moderate idiopathic or diabetic gastroparesis
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know